Impact of anxiety on the brain

A stressful world

Every day the average person goes through a plethora of stressful events. We go to work, school, or take part in other tasks that demand a lot from our brains. We never have the chance to “get away” from our stressors with the invention of email and smartphones. They continuously remind us of things we have to get done and interrupts our downtime. It seems like many of us, especially college students, have never ending lists of things to do before we get any time to relax. Stress has become such integral component of our daily lives that we are beginning to see more and more cases of anxiety disorders. Research has shown that physical changes occur in our brains as they respond to stress suggesting semi-permanent effects. Our DNA is modified is response to prolonged anxiety causing changes in neural connections. These changes can cause problems with memory and can even lead to heightened anxiety. The topic of stress and anxiety is an important one as it is a common feeling felt in most people and is a prevalent issue in mental health.

What’s going on in our heads?

Anxiety is the brain is a difficult mechanism to piece to together even for top anxiety scientists. Nevertheless, there are some concrete pathways that we for sure know are involved in stress and anxiety. The stress response begins in the brain. The hypothalamus or pituitary gland release hormones into the blood to induce a change in body physiology. Ultimately, these hormones change how we feel and are an integral component of our fight or flight response. However, an imbalance in these signaling hormones can lead to anxiety disorders.

The hippocampus is a structure in the brain utilized in memory consolidation. This structure includes a lot of cells containing receptors for the hormones described previously. It is believed that these hormones are essential for proper memory formation and that too much or too little of them will cause problems with anxiety. In cases of PTSD, it is believed that there are too many of these hormones in the hippocampus leading to a strong association to be made. This results in the formation of a memory that could trigger feelings of anxiety or stress in unnecessary circumstances. The excess hormone in the hippocampus pairs with action of a neurotransmitter called glutamate. Together, these two molecules cause a cascade of signaling to occur resulting in modification of our DNA. This change in DNA causes new genes to be turned on that improve our ability to learn. In many cases this is a good thing, but in cases of PTSD, this means that traumatic events are remembered very vividly and can cause excessive feelings of anxiety. Today, scientists are working to find out how to alleviate the memories of traumatic events while preserving normal functioning in learning and memory.

So what’s the deal? Is anxiety good or bad?

Generally, anxiety is a good mechanism to help keep us safe. If a specific situation causes anxiety, we are generally going to avoid contact with that situation. Perhaps you get anxiety being around snakes so you never touch them or get near them. From an evolutionary prospective, this is very beneficial. Snakes can be dangerous and avoiding them through prevention of an anxious feeling would be beneficial overall. The problem arises when anxiety occurs in situations where it shouldn’t. Social interactions with people you know to be good should not cause a severely heightened sense of anxiety. There is no danger to be anxious about in this situation so there is no reason for us to try to avoid it. Yet many people do get this feeling at seemingly random times. Some people don’t even have to be in a stressful situation to feel stress, they just have to be reminded of one. Perhaps an image vaguely relating to a traumatic event brings on these feelings of anxiety. This is the case for many people with PTSD who experience trauma and are unable to weaken the association of their anxiety to the memory of the event. In these cases, anxiety is a very negative response and holds no survival value. We should remember to avoid dangerous things but these memories should not lurk into safe situations. Further research is necessary to help treat individuals with anxiety disorders because they can have profoundly negative impacts on the person’s quality of life.

Exercise is the New Medicine for Your Brain

The importance of regular exercise for our physical health is drilled into us starting in elementary school gym class. However, there are also mental health benefits that result from exercise. In multiple studies it has been found that exercise has been shown to reduce anxiety levels.

How does this work?

When one experiences a psychological stressor, the pathway in the brain that responds to this is the NDMAR-ERK-MAPK pathway. This process involves multiple steps of phosphorylation and acetylation, eventually resulting in the opening of the chromatin and the alteration of gene transcription. When this pathway is over-activated, it leads to the formation of strong, long-term memories  which are often times associated with anxiety and post-traumatic stress disorder (PTSD).

It is thought that the decreased anxiety levels seen from exercise is due to changes in the GABAergic system. GABA is an inhibitory neurotransmitter; therefore, the increased gene transcription of a GABA synthesizing enzyme allows for more GABA to be created and excreted. With increased levels of this inhibitory neurotransmitter, it is less likely that this anxiety-related pathway will be over-activated leading to decreased levels of anxiety and better response to stress.

These conclusions were determined through experiments with mice and rats, but there was a similar experiment conducted with humans at UC Davis. Participants who exercised showed higher levels of GABA but they were not put through a stress tests like the experiments with mice and rats were. The similar increase in GABA indicates the similar conclusions of the two studies.

Maintaining a Balance

It is crucial that this GABAergic system maintains the correct balance of GABA. As previously discussed, not enough GABA can lead to anxiety and PTSD-related symptoms, because there is not enough inhibitory signaling going on in the brain. On the contrary, too much GABA can be dangerous as well. This excess of inhibitory signals can promote carelessness and cause an individual not to be as aware of danger.

Current Treatments

Medications– used to treat symptoms of anxiety and PTSD but do not target the cause. These are the most commonly used classes of medications.

  • SSRIs (Serotonin Reuptake Inhibitors) which are also antidepressants: Fluoxetine, sertraline and paroxetine all work to decrease anxiety, depression and the panic associated with PTSD
  • Atypical antipsychotics– risperidone, olanzapine and quetiapine are mostly used to treat PTSD to help with agitation and paranoia
  • Mood  stabilizers – sleeping tablets or anti-anxiety medications

Psychotherapy- also referred to as ‘talk therapy’ is very effective for treating PTSD. The patient meets once a week with the therapist for 3-6 months. These therapies include teaching the patient how to reframe their thoughts surrounding the traumatic event and learning how to be in control of one’s feelings

Usually a combination of medication and psychotherapy is used in the treatment of PTSD. However, with the recent research regarding the benefit exercise can have on mental health, that may become part of the treatment plans for this disorder. It would be a more natural way of using the body’s natural functions to try heal the pathways that have been impaired in the brain.

The Memories We Make

Fig. 1

Memories make up who we are as individuals. When memories are interrupted, degraded, or inhibited, we see cases of dementia such as Alzheimer’s Disease–what we discussed last week. There are many different types of memory that people may form (Fig. 1). Explicit memory refers to memories that individuals can consciously discuss whereas implicit memories cannot be distinctly defined or stated. A type of implicit memory is procedural memory. This type of memory exists for skills and actions–like remembering how to ride a bike or play a sport. Procedural memories may also be referred to as “muscle memory” in popular language. Episodic memory is a type of explicit memory that refers to memories regarding autobiographical events–the who, what, when, where, and why. Semantic memories tend to involve facts and concepts.

This week in class, we discussed traumatic memory in regards to PTSD, Anxiety, Depression, and other psychiatric illnesses. Traumatic memory, also called somatic memory, are strong, resilient memories formed following traumatic, psychologically damaging events. In order for an individual to form a traumatic memory, that same individual has to personally experience the trauma. If a societally traumatic event happens around an individual, a memory formed for that event would be considered a flashbulb memory. As defined in 1977 by Brown and Kulik, flashbulb memories refer to emotionally charged memories formed upon learning about a public emotionally charged or traumatic event. These memories are not autobiographical in nature–they did not occur to the person, but around the person. The name, “flashbulb memories,” stems from their nature of allowing the individual to visualize themselves as they were when the event happened, as if they had taken a picture of themselves during that moment.

Although the nature of the memories may differ, flashbulb memories may be similar to trauma or stress induced memories. Originally, Brown and Kulik, 1977, hypothesized that due to their emotional strength, flashbulb memories might be formed using a unique pathway. The researchers also believed that flashbulb memories were not subject to change–that they were stronger than normal memories and not susceptible to the inevitable forgetting and reforming that other memories experience. More recent research has shown the opposite of Brown and Kulik’s claim regarding the resilience of flashbulb memories. A study by Talarico and Rubin, 2003, used a test-retest methodology to find substantial inconsistencies in flashbulb memory recall–from the initial to the latter recall of the memory.

When it comes to traumatic memories, the study of flashbulb memories has helped researchers understand memories that stem from psychological stress. Specifically, one study looked at the memories made by individuals who were not directly impacted, but lived in New York City during the events occurred on September 11th, 2001. The study assumes that the individuals created flashbulb memories of 9/11 and found, using brain imaging, that their amygdalae still showed increased activity levels three years following the events. These individuals were not at Ground Zero, but lived or worked near the epicenter of the attacks. This finding is important for the distinction between flashbulb memories and traumatic memories. Due to their similar nature, it remains unclear if molecular differences exist between the two types of memory.

Fig. 2

When discussing these two types of memory, their similarities seem to outweigh their differences. The major difference between the two seems to be whether the individual themselves experienced the traumatic event or if the individual witnessed the traumatic event as an outside observer. Regardless of this characteristic difference between traumatic memories and flashbulb memories, they likely utilize the same formation pathway (Fig 2). Research understands that once formed, both types of memory may lead to the onset of PTSD, Anxiety, Depression, or other psychiatric illnesses if not properly treated soon after the traumatic event. Although different treatment options exist such as pharmaceuticals like SSRIs, atypical antipsychotics, or mood stabilizers, treatment that utilizes psychotherapy tends to be more successful. Common psychotherapy treatment options include Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and Eye-Movement Desensitization and Reprocessing (EMDR). Each therapy aims to address and process the negative thoughts one possesses due to the traumatic event. Regardless of the treatment process, it remains important to address negative thoughts–as a result of the trauma–as soon as they appear. The earlier the intervention, the less likely an individual is to develop psychiatric illness following a traumatic event.

Is your sweet tooth causing Alzheimer’s Disease?

Alzheimer’s Disease (AD) is one of the most saddening diseases. AD not only affects the patient, it could wreak emotional havoc on the family and friends of the patient. AD is the most common cause of dementia among older adults1. Dr. Alois Alzheimer was the first to diagnose this wretched disease after a postmortem study. He noticed changes in the brain tissue of a woman who had died of an unusual mental illness in which her symptoms included memory loss, language problems, and unpredictable behavior. The postmortem examination found that she had many abnormal clumps (amyloid plaques) and tangled bundles of fibers (neurofibrillary tangles)1. To this day, these plaques and tangles are still the main features of AD’s pathogenesis. What causes these plaques and tangles to form? I was surprised to find that the answer is closely related type 2 diabetes.

 

Insulin Signaling:

This signaling mechanism is initiated by the binding of insulin to a transmembrane tyrosine kinase receptor. The insulin receptor (IR) autophosphorylates tyrosine residues located in the intracellular portion of the receptor. Rapid phosphorylation of tyrosine residues of insulin receptor substrate 1 through 4 (IRS-1 through IRS-4) occurs quickly after the initial phosphorylation. The IRS residues use a number of pathways, amongst the most prominent is the PI3K/Akt/mTOR pathway2. IRS are widely distributed in the brain and enriched in the hypothalamus, hippocampus, cerebral cortex, cerebellum, and olfactory bulb2.

 

Insulin Defect in AD:

Postmortem studies of AD brains have revealed defective insulin signaling2. Insulin resistance  can be caused by b-amyloid oligomers (AbOs), proximal toxins that conglomerate in AD brains2. AbOs cause rapid insulin insensitivity when exposed to hippocampal neurons2. Different molecular mechanisms are associated with this defective insulin signaling that connect AD and diabetes.

Fig 1. Representation of the insulin signaling pathway and associated mechanisms in AD and T2D.

 

  1. Inflammation:

Insulin resistance in diabetes can be attributed to mild, sustained inflammation of peripheral tissue2. Fat accumulation in the adipose tissue causes macrophage recruitment and secretion of TNF-a, a proinflammatory cytokine2. Similarly, AD brains are also characterized by sustained chronic inflammatory state. Microglial activation and secretion of proinflammatory cytokines, such as TNF-a, can be instigated by AbOs in vitro, in mice2. Moreover, AbO induced insulin resistance requires the TNF-a receptor (TNFR)2.

 

  1. Gangliosides:

Insulin resistance may proceed by another mechanism that includes gangliosides, complex lipids that are located in the gray matter of the human brain. Mounting evidence exhibits that interactions between ganglioside GM3 and IRS-1 could be that mediator of insulin resistance. Inhibition of GM3 ultimately causes the uncoupling of IR from IRS-1 and consequent insulin resistance2. GM1 ganglioside has also been associated with insulin resistance. This sensitivity is caused by a build-up of GM1, due to uncertain mechanisms2. In AD, the interaction between AbOs and the ganglioside GM1 has been object to excessive investigation. GM1 is a binding site for AbOs on the neuronal membrane. This action promotes aggregation of the peptide into the toxic amyloid structures2. AbOs aggregate forming the plaques that are common with AD pathogenesis. GM3 is also a culprit in AD pathogenesis. This ganglioside may accumulate in the membrane due to AbOs triggering defective metabolism of GM32. As aforementioned, a build-up of gangliosides causes insulin resistance; thus AD could ensue.

 

  1. mTOR:

In the brain, development is heavily dependent on mTOR and its incorrect activation can lead to neurodegeneration2. mTOR activation has been correlated with IRS-1 inhibitory phosphorylation, which uncouples the interaction of IRS-1 with IR2. Insulin resistance in AD has also been characterized from increased activation of the mTOR pathway and inhibitory phosphorylation of IRS-12. The mTOR pathway is major interest between insulin resistance and AD, as it may impact insulin signaling regulation, autophagy, and subsequently, AbO clearance; all of which are common mechanisms of AD pathogenesis.

 

  1. PTP1B:

Recent research demonstrates important roles PTP1B in the CNS. The protein tyrosine phosphatase 1B (PTP1B) is an important factor of insulin signaling2. PTP1B is a positive regulator of microglia-mediated neuroinflammation2. This neuroinflammation is s common event in AD pathogenesis that is implicated by the development of neuronal insulin resistance.

 

Impact of Alzheimer’s Disease:

These studies suggest a strong association between AD and T2D. Many mechanisms have been explored; however, every mechanism of AD and T2D seems to have one common modulator – insulin resistance. Type 2 diabetes (T2D) nearly doubles the risk of dementia2. As type 2 diabetes prevalence increases throughout the United States, increasing risk of AD increases as well. In my opinion, AD is one of the most devastating diseases known. The disease takes the mind, then it takes the body. AD strips patients of their memories and cuts them off from the world. Families are forced to watch their loved ones with AD forget who they are and the people in their lives’. Hopefully, watching what we consume food wise will decrease the risk of developing AD. Next time, ignore your sweet tooth and put down the cupcake.

 

  1. https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet
  2. https://moodle.cord.edu/pluginfile.php/723477/mod_resource/content/0/2018%20AD%20and%20insulin%20signaling.pdf

“Grandma, I’m not ______” What’s Happening to Our Memories?

Imagine in you and your two closest friends when your 80. Odds are one of you will have Alzheimer’s. Yes Alzheimer’s, that scary disease where your loved one starts to forget their life including you, or perhaps in the future you start to forget your loved ones. You may be more at risk to getting it than you would think… but you can also combat this pretty easily with diet, exercise, and a love for learning. 

The National Institute on Aging defines Alzheimer’s Disease as “an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks.” The Alzheimer’s Associations 2018 data shows that presently 5.7 million American’s have Alzheimer’s Disease and this number is expected to rise to 14 million by 2050. They note that every 65 seconds another person develops Alzheimer’s, a disease killing 1 in 3 American seniors which is more than breast cancer and prostate cancer combined.

There are two forms: late-onset in which the symptoms appear in their mid-60s, and early-onset where the symptoms can appear between their 30s and mid-60s. Early-onset is very rare, only about 10% of Alzheimer’s cases, and due to genetics.

Image result for alzheimer picturesYet with all our technologies and knowledge about the disease we can’t truly diagnose AD until postmortem as it is determined by physical changes in the brain. These physical changes include build up of plaques and neurofibrillary tangles. Neuronal death and connection loss are also significant changes, these are simply not visible.

The form and severity of Alzheimer’s one has depends on genetic and environmental factors. As I mentioned earlier early-onset is most commonly characterized by mutations in 1 of 3 genes: APP, PSEN 1, and PSEN 2. These mutations play into the breakdown of APP which is part of the production of the harmful forms of amyloid betas that form the amyloid plaques. Early-onset has helped scientists identify some of the key steps in the formations of these brain abnormalities that are generally found in late-onset.

The causes of late-onset are not yet completely understood. They likely contain a combination of genetic, environmental, and lifestyle factors that affect someone’s risk for developing Alzheimer’s. While they haven’t found specific genes that directly cause late-onset they have found a genetic risk factor in the APOE gene that can increase risk depending on the form. By 2015, they had also discovered and confirmed 33 regions of interest in the Alzheimer’s genome.

Environment and lifestyle play significant factors in the risk associated with development. Medical conditions such as obesity and diabetes, toxins, brain injury, and even diet play a role in Alzheimer’s. The risks increase as you age, accumulating up as different changes in the brain occur. Some are changes that can harm the neurons such as shrinking of areas, inflammation, free radical production, and energy production breakdown.

So preventative measures, that is what everyone wants to know. Its pretty easy actually… Diet, exercise, and keep learning! 

Diet & Exercise – I go into depth about Alzheimer’s and Type 2 Diabetes further down, but the gist is healthy diet and exercise keep your body healthy. They decrease you chances of developing other medical conditions in the present and the future.

Learning – This one is surprising isn’t it? It’s actually a lot simpler than you would guess and it is highly important. As Alzheimer’s involves the loss of neural connectivity the more connections you make, by learning, are vital. The more you have means the more you can lose and the less affects you are likely to see. The video below talks about a study that found this, Dr. Genova mentions it towards the end.

Diabetes and Alzheimer’s

Recent studies have shown that there is a link between type-2 diabetes (T2D) and Alzheimer’s disease (AD). One study showed that T2D nearly doubles the risk of dementia and conversely AD patients are at an increased risk to develop T2D. The commonality between them is insulin. Insulin is a hormone, primarily created in the pancreas, that controls blood sugar levels and aids in using and storing energy. In the brain this insulin works to protect the neurons, strengthen connections, plays a role in cognition and is required for long term memory.

This insulin resistance stems from many sources, the image below goes over the similarities between the two diseases.

Because of all this, medications that have been approved to treat diabetes and obesity can help counteract some effects of AD in animal models. The mechanisms above may provide new targets for disease modifying therapies.

Everyone will be impacted with Alzheimer’s somehow at least once in your life. My story was with my great grandmother who suffered from dementia for years until she died this past summer at the age of 98. Even 8 years ago when we went to visit for her 90th birthday, she couldn’t recognize me. She knew who I was once I explained but it did not click. However, until her dying day, even when she couldn’t really take care of herself, out of all her grandchildren, great grandchildren, and great great grandchildren grandma remembered my little brother the most. He was the namesake of her husband and was in a way the favorite because of that special connection. He held that emotional bond, and even with Alzheimer’s those can’t be broken easily. The memories may be lost but the feelings are forever.

Uncovering the Foundations of an Unlikely Couple: The Link Between Alzheimer’s and Type 2 Diabetes

 

The Relationship:

When considering an individual suffering from Alzheimer’s Disease (AD), one doesn’t often associate Type II Diabetes (T2D), or vice versa. However, this may become the new norm as studies are now showing a link between these two diseases. When you take a closer look, many similarities exist, turning this relationship toxic.

What is Alzheimer’s:

Alzheimer’s is a neurodegenerative disorder characterized by progressive mental deterioration due in part to the buildup of amyloid plaques and neurofibrillary tangles in the brain. This type of dementia is the most common worldwide, causing problems with memory, thinking, and behavior. There is no treatment currently capable of reversing, stopping, or significantly slowing down the progression of this disease, making the study of its origination crucial to future treatment.

http://az616578.vo.msecmd.net/files/2016/04/10/635958482997470921934663329_alzheimers1.jpg

 

What is Type II Diabetes:

Type II Diabetes, or noninsulin-dependent diabetes, is a disease that affects the way that the body metabolizes sugar. This disease is characterized by high blood sugar, insulin resistance, and relative lack of insulin. T2D primarily occurs as a result of obesity and lack of exercise and is seen to be becoming far more prevalent in recent years, likely due the poor diet and lifestyle exhibited by the American society.

 

http://www.frontiersin.org/files/Articles/140046/fnins-09-00204-HTML/image_m/fnins-09-00204-g001.jpg

The Connection:

Insulin, as we know, plays a large role in the body as a regulator of blood glucose. However, it also has an important role in brain function. Insulin is now understood to play a large part in neuroplasticity, neuromodulation, as well as memory and cognition. Lack of insulin function, as characterized by T2D, can disrupt these pathways, leading to common symptoms seen in Alzheimer’s disease.

Insulin function has been found to be disrupted by prolonged inflammation in the brain as seen in both T2D and AD. In individuals experiencing T2D, the accumulation of fat causes the accumulation of inflammatory molecules. It is likely that obesity associated systemic inflammation causes excesses circulating free fatty acids. These circulating cytokines, free fatty acids, and immune cells reach the brain and initiate local inflammation, including microglial proliferation. This chronic inflammation not only disrupts the insulin pathway in the brain, but also causes synaptic remodeling and degeneration through the overactivation of microglia.

In Alzheimer’s, prolonged inflammation of the brain is a characterizing factor of the disease. This chronic inflammation is largely due to the overactivation of microglia, as seen in T2D. Microglia work to degenerate the buildup of amyloid plaques commonly found in the brain of individuals suffering from Alzheimer’s. When these macrophage-like molecules can’t keep up, they continue to release pro-inflammatory cytokines in response, often damaging neurons and synapses in close proximity. This leads to neurodegeneration. Inflammation itself, such as from T2D, can also trigger the activation of microglia as they both respond to, and cause, neuroinflammation.

 

https://www.sigmaaldrich.com/content/dam/sigma-aldrich/articles/biology/microglia-in-neuroinflammation/neuroinflammation-microglia.jpg

Importance:

Though there is no cure for Alzheimer’s, we have found that due to its strong link to T2D, diet may play a role in in alleviating the onset and progression of this neurodegenerative disease. It is important for not only your physical heath, but also future neurological heath, to be cautious of the food you put into your body as it may have a long-term effect.

For those of us who have experienced the terrors of watching a loved one suffer through the horrors of AD, we know the impacts that this knowledge could have. Alzheimer’s is not only detrimental for the individual, but also significantly traumatic for the family as well. Though it is easy to say, “that won’t happen to me” or “I’ll deal with that when I get there”, it may be vastly beneficial to both you and your loved ones to be aware and proactive as it could affect your future and quality of life.

Bibliography:

https://www.sciencedirect.com/science/article/pii/S0889159114000889

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237995/

https://en.wikipedia.org/wiki/Diabetes_mellitus_type_2

https://moodle.cord.edu/pluginfile.php/723477/mod_resource/content/0/2018%20AD%20and%20insulin%20signaling.pdf

Can a poor diet lead to Alzheimer’s? The link between type two diabetes and Alzheimer’s.

Alzheimer‘s disease or AD is a degenerative disease that leads to memory loss, and decline of cognitive functions. Type 2 diabetes (T2D) is caused by problems due to insulin resistance. How are these two different diseases related? Is glucose regulation related to neurons dying? Research has shown that having type 2 diabetes is a major risk factor for AD, and vice verses. These two diseases are more alike than they appear. The inflammation and insulin pathway are two molecular mechanisms that explain the correlation between the two diseases.

 The Insulin Pathway

In order to understand the insulin pathway we must first talk about insulin resistance. This resistance takes place in both AD and type two diabetes.

Type 2 Diabetes: In order to breakdown glucose the body needs insulin. In T2D insulin does not work properly. This leads to high levels of glucose in the body, which causes high blood sugar. Having problems with insulin production can lead to other problems in the body, like in the brain for example.

 Alzheimer’s: Insulin resistance can be shown in postmortem brains of people who suffered from AD. This impaired insulin signaling can be seen clearly in the hippocampus region of the brain. It is thought that insulin resistance in an AD brain may be caused by the build up of amyloid beta plaques. However, this is one hypothesis. There are many more hypotheses being developed surrounding the topic of insulin resistance in the brain.

Inflammation

Insulin resistance plays a large role in the inflammation found in type 2 diabetes, and AD.

Type 2 DiabetesObesity, due to poor diet is often linked to the development of insulin resistance, and ultimately T2D. When fat cells accumulate, inflammatory cells follow. One of the main inflammatory cells involved in T2D is the cytokine TNF-α. 

Alzheimer’sChronic inflammation is one of the characteristics of AD. The inflammation seen in AD is caused by the immune cell called microglia. The microglia are responsible for the protection and remodeling of synapses in the brain, and help contribute to neuroplasticity. Microglia often produce inflammatory cells in response to increased accumulation of amyloid beta plaques. Research has shown that in order for amyloid beta to cause insulin resistance, and therefore inflammation the cytokine TNF-α must be present.

What does this have to do with my diet?

Our society values convenience, so when given the choice between fast food and taking the extra time to pack food it is not surprising that many of us would choose the fast food option. These poor dietary choices combined with spending your free time watching Netflix can lead to serious problems. Nearly 40% of Americans are obese, and 30% of those who are overweight or obese have type 2 diabetes. While maybe these statistics alone aren’t enough to change your mind maybe this next statistic will make you question whether that extra piece of cake is truly worth it. Having T2D doubles your chances of developing Alzheimer’s Disease. Now I am not saying to ditch fast food entirely, I enjoy treating myself too, but the next time I am given the option of packing my lunch or get fast food, I’ll be packing my own.

 Why should you care?

There is no cure for Alzheimer’s Disease, so it is important to take preventative steps now. Remember, little changes can make all the difference.

  • Pack a meal for on the go instead of getting fast food
  • Watch TV or Netflix while you work out
  • Find health snacks that you enjoy
  • Take time for yourself!! Whether it by cooking dinner, or working out try to find healthy practices to implement now. Trust me, your future self will thank you.

Image 1  https://www.psychologytoday.com/us/blog/diagnosis-diet/201609/avoiding-alzheimer-s-disease-could-be-easier-you-think

The 5 Proven Ways to Prevent Alzheimer’s

What is Alzheimer’s Disease?

Alzheimer’s Disease (ASD) is a form of dementia that affects memory, thinking, and behavior, primarily in older individuals; the majority of people with ASD are over 65. The most important thing to know about Alzheimer’s is that it is not a normal part of aging, and it can be prevented through lifestyle choices. The disease progresses from mild memory loss during the early stages to inability to carry a conversation or respond to environment as an affected individual approaches death.

What Goes Wrong in the Brain?

 There are two structures that appear in ASD brains that experts point to as primary characteristics of the disease:

  • Beta-Amyloid Plaques – protein fragments that build up in between nerve cells
  • Neurofibrillary Tangles – tangled tau proteins that build up in cells

These plaques and tangles build up specifically in brain areas important for memory before other areas in Alzheimer’s patients, such as the hippocampus. The plaques and tangles are not well understood by scientists, but we do know that they can destroy nerve cells, leading to memory loss.

The two buildups in the brain are caused by a variety of factors, and they are classified into three types of Alzheimer’s Disease:

Type 1 – Genetic and inflammatory based

Type 2 – Hormones and infection based

Type 3 – Brain pathway dysfunction

While the physiological mechanisms that lead to ASD are complex, there are 5 medically proven ways that can prevent all forms of Alzheimer’s.

How Can the Disease Be Prevented?

 The first thing to understand about preventing ASD is that 99% of drugs that have been formulated to treat the disease have failed. In fact, when drugs that target Beta-Amyloid plaque in the brain are used, ASD can get worse because Beta-Amyloid is a protein the brain produces to protect itself against inflammation.

Secondly, some people are more genetically predisposed to develop the disease. The gene that is most commonly associated with late-onset Alzheimer’s is the APOE gene, which can be tested for. However, many people who have this gene don’t get Alzheimer’s, and many people get the disease who don’t have the APOE gene. So, here are the five clinically proven markers to keep under control to prevent ASD.

  1. Inflammation

Most people are aware that chronic inflammation can lead to disease. However, many people don’t know exactly how to avoid and prevent inflammation. The three most important factors to ditch chronic inflammation are diet, exercise, and sleep:

Diet

  • Eat much more omega-3s than omega-6s, which means more fish and flaxseed and less vegetable oil.
  • Avoid processed foods and sugars.
  • Avoid foods that are commonly inflammation triggering, such as gluten and dairy.

Exercise

  • Make sure to strength train at least 2 days a week.
  • However, know how your body responds to exercise and don’t over train.

Sleep

  • Get at least 7 hours of sleep per night, or up to 9 hours depending how much your body needs.
  • Getting the same amount of sleep every night is best.
  1. Nutritional deficiencies

Lab testing can be performed to measure nutritional deficiencies. Common deficiencies include iron, iodine, vitamin B, vitamin B12, calcium, and magnesium. Any of these deficiencies can have adverse health effects, and they can be simply supplemented for when the deficiency is known.

  1. Toxic exposures

There are over 77,000 man-made chemicals in the environment, so it is impossible to avoid all of them, but measures can be taken to reduce toxic exposure.

  • Drink reverse-osmosis water – city water can be contaminated with halogens, antibiotics, and other prescription drugs.
  • Take preventative measures in situations with high toxic exposure risk
  • Use natural health/beauty products – deodorants and soaps are loaded with toxic chemicals
  1. Genetics

Some people are more genetically predisposed for Alzheimer’s (APOE gene mentioned previously). By getting a genetic test, you can learn if you are at risk, and diet and lifestyle recommendations will be made by a health expert.

  1. Viruses and infections

The presence of a virus such as herpes can cause chronic inflammation. Viruses can be repressed if the immune system is functioning properly. The best ways to boost immune function is through proper diet, exercise, sleep, and supplementation.

Food for Thought: The connection between type 2 diabetes and Alzheimer’s

Image result for alzheimers and diabetes

Both Alzheimer’s disease (AD) and type 2 diabetes are products of insulin resistance. Type 2 diabetes has insulin resistance in the peripheral organs, muscle and adipose tissue, while in AD, the insulin signaling pathway in the brain is impaired. This common molecular mechanism between the two diseases is theorized as the reason why 70% of individuals diagnosed with Type 2 diabetes will eventually develop Alzheimer’s. This connection has led to nicknaming AD as Type 3 diabetes. So what is insulin resistance? Is it actually a good theory for the risk of developing Alzheimer’s? Let’s take a look.

Insulin Resistance

Insulin is a hormone that regulates the amount of glucose in the blood. When insulin binds to a tyrosine kinase receptor, the phosphorylation or activation of proteins occurs, sending a signal down the pathway. This signal allows for the uptake of glucose, fatty acids and amino acids into cells where they are stored in the liver, adipose tissue and muscle as nutrients. If these nutrients are not able to be taken up, diabetes occurs. In the case of Type 2 diabetes, the body becomes resistant to insulin, so the signaling pathway never occurs to cause the uptake of these nutrients. The body’s resistance to insulin can be due to the inability of the insulin receptors to bind insulin and unlock the cells to allow glucose and other molecules into the cell.

Type 3 Diabetes

The term “type 3 diabetes” is given to Alzheimer’s because it has the insulin pathway impairment that is a trademark of diabetes, but in AD it occurs in the brain. The brain dysfunction occurring in AD has similar molecular and biochemical mechanisms as type 1 and type 2 diabetes. The reason why AD would be another form of diabetes and not just a symptom of type 2 diabetes is due to the brain specific issues that are disrupted. These issues stem from abnormalities in gene expression that encode insulin, insulin growth factor (IGF), insulin growth factor peptides, receptors and more signaling mechanisms. Problems with gene expression lead to the disruption of signaling pathways that control insulin and insulin growth factor neuronal survival, along with problems with tau expression, energy metabolism, and mitochondrial function. Together, these abnormalities create the symptoms observed in Alzheimer’s.

Is it a viable hypothesis?

There are multiple different studies showing that abnormalities with insulin and IGF signaling mechanisms occur in the early stages of Alzheimer’s, so they likely play a large role in the disease’s pathology. While AD and diabetes have a lot of similarities, it has not yet been entirely determined what the role of having type 2 diabetes plays in the development of AD. However, there are obvious conclusions that can still be drawn. Since issues with insulin pathways stem from poor diet, excess weight and inactivity, having a healthy lifestyle will keep you out of risk for issues with these pathways. Therefore, if these pathways stay healthy and functional, you will be less likely to develop both type 2 diabetes and Alzheimer’s disease. Alzheimer’s does have a genetic component to its development as well, so staying healthy may decrease the chances that these genetic abnormalities causing the development of the disease. While the research into disease pathology continues and more and more connections are found, it is important to remember the role you play in your own health.

Image: https://www.google.com/search?biw=1392&bih=684&tbm=isch&sa=1&ei=BhO9W9ycNc_8jwT6sLz4Bg&q=alzheimers+and+diabetes&oq=alzheimers+and+diabetes&gs_l=img.3..0i10i24.62947.69763..69890…2.0..0.104.1675.24j1……1….1..gws-wiz-img…….0j0i67j0i10.oPF5crPJtJc#imgrc=_0-B23ouAi8HlM:

Bridging the gap between Alzheimer’s disease and type II diabetes

100 million American adults either have type II diabetes or prediabetes (if left unregulated will lead to type II diabetes in 5 years).

It is estimated that 5.7 million Americans are living with Alzheimer’s.

Both represent a significant physical and economic burden to both the impacted individual as well as the remainder of society. At first glance, it may seem like these two diseases are unrelated, however, recent studies have identified a link between the two.

How is type II diabetes characterized?

Type II diabetes is characterized by insulin resistance. Insulin is a hormone your body releases as a response to increased blood sugar levels (which are directly dependent on eating habits). After a meal, blood sugar levels rise, and the body sends insulin to tell cells to store sugar inside the cells rather than in the surrounding bloodstream. Initially, the body will release more insulin to accommodate the increased blood sugar levels, but overtime the body cannot make enough insulin to keep blood sugar levels normal.

How is Alzheimer’s characterized?                                              

Alzheimer’s can only be diagnosed for certain by taking tissue samples and observing a build-up of neurofibrillary tangles and amyloid-beta plaques. A brain with Alzheimer’s also experiences significant brain atrophy, as seen in the image below.

These physical indicators are difficult to diagnose short of taking a tissue sample, therefore an Alzheimer’s diagnosis is determined almost exclusively on the presented symptoms of memory loss as well as mild cognitive impairment.

How are they connected?

  • Inflammation

Insulin resistance as seen in type II diabetes is proposed to be a result of chronic inflammation in peripheral tissues of an increased amount of fat tissue. Although not caused by an excess of fat tissues, brains with Alzheimer’s have increased levels of inflammation as compared to a “normal brain.”

Additionally, amyloid-beta plaques in the hypothalamus (part of the brain that regulates hormones) have been shown to cause dysregulation of metabolism in peripheral tissues. Amyloid-beta plaques also mediate the further release of various inflammatory factors causing a cascade-like inflammatory response.

Evidence points to sustained inflammation being a mechanism of insulin resistance which is present in both type II diabetes and Alzheimer’s disease.

  • Gangliosides

The brain has insulin receptors that are involved in pathways in the brain. Proper signaling is highly dependent on certain molecules being in the correct location. A cell can be portioned into different areas that accomplish different tasks- known as microdomains. An important factor of microdomains is cholesterol which acts akin to glue holding proteins together at the membrane, thereby making a more efficient signal, simply because the necessary molecules are close together. Gangliosides are commonly associated with microdomains and facilitate many reactions in the body; notably, the conversion from a single amyloid-beta molecule to a full blown plaque by having many aggregate together, a trademark of Alzheimer’s.

Diet has been shown to directly modify the type and frequency of gangliosides that become incorporated into a cell. Insulin receptors can be displaced from its proper location in a microdomain, essentially making it ineffective and modifying proper insulin signaling.

Important Takeaways:

  • Type II diabetes and Alzheimer’s disease are related, and one increases the risk for the other
  • Establishing a link between the two provides insight into two very prevalent diseases in the United States, which in turn could be helpful in finding particular therapies or treatments for one or both diseases
  • Inflammation plays a critical role in the development of type II diabetes and Alzheimer’s alike
  • Gangliosides have the potential to displace insulin receptors in the brain contributing to insulin resistance
  • Taking measures to ensure you do not develop type II diabetes lowers your chances of developing Alzheimer’s at an older age

Sources:

https://www.nia.nih.gov/health/alzheimers-disease-fact-sheet

https://www.alz.org/alzheimers-dementia/facts-figures

https://www.cdc.gov/media/releases/2017/p0718-diabetes-report.html

http://www.diabetes.org/diabetes-basics/type-2/

https://www.ncbi.nlm.nih.gov/pubmed/29129775

Spam prevention powered by Akismet